Pathogenesis of cancer

Statement 2: The basis for the “generation” of a malignant stem cell is the return of a tissue mononuclear cell, which has genotypic and epigenetic changes, to the embryonic state during mitosis, a block of differentiation at the pluripotent or unipotent level and transformation.

Statement 3: The mechanism of “generation” of a malignant stem cell is a complex multi-stage process, when genotypic changes in a bone marrow mononuclear cell under carcinogenic influence sequentially appear, epigenetic changes in the same but tissue mononuclear cell under the influence of “super conditions” of an isolated microcavity, and mitosis is the starting point for their implementation.

Statement 4: The polymorphism of malignant cells is due to the variety of options for their “nucleation”, maturation and differentiation, as well as their own evolution and the influence of the microenvironment.

Statement 5: A malignant focus is an independent structural and functional formation that has characteristic features and conditionally repeats the structural organization and functioning of the red bone marrow.

Statement 6: The stages of formation and successive change of generations of malignant stem cells conditionally repeat the stages of formation and successive change of generations of stem cells of embryonic hematopoiesis.

Statement 7: The malignant process, as an independent system, is capable of self-organization and self-regulation; many evolutionarily determined mechanisms lie in its occurrence and development.

CONCLUSIONS

Based on the above, the following conclusions can be drawn:

1. The precursor cell of the primary malignant stem cell of solid tumors is a tissue mononuclear cell (Monocyte), which has genotypic and epigenetic changes.

2. The primary mutation of the nuclear DNA of the Monocyte genome occurs in the red bone marrow after the carcinogenic effects of the initiator (ionizing radiation, endo- and exocarcinogens).

3. From the red bone marrow, the monocyte enters the bloodstream, where it remains from 36 to 104 hours (1.5–4.5 days), and then leaves it according to a stochastic principle, migrating to the focus of chronic inflammation.

4. The primary mutation of the nuclear DNA of the Monocyte genome can be determined using sequencing, after isolating the Monocyte from the circulating blood of a person with a solid malignant tumor.

5. Knowing the primary mutation of the nuclear DNA of the Monocyte genome, as a precursor cell of a cancer cell, it is possible to create a therapeutic anti-cancer DNA vaccine “on demand”.

6. The basis for the “generation” of a malignant stem cell is the return of a tissue mononuclear cell, which has genotypic and epigenetic changes, to the embryonic state during mitosis, a differentiation block at the pluripotent or unipotent level and transformation.

7. The mechanism of “generation” of a malignant stem cell is a complex multi-stage process, when mutations in the nuclear DNA of a bone marrow mononuclear cell successively appear under carcinogenic influence and epigenetic changes in the same, but tissue mononuclear cell under the influence of “super conditions” of an isolated microcavity, and mitosis is the starting point for their implementation.

8. Initially, this will be an “on demand” vaccine, then it is possible to use a vaccine based on a set of primary mutations in the nuclear DNA of the genome of the progenitor cell of the cancer cell.

LITERATURE:

1. Shalin S.A., Keskinov A.A. Mononuclear opcogenesis. 2010, 146 pp.

2. Bozhenkov Yu.G., Shcherbyuk A.N., Shalin S.A. Practical pancreatology. Guide for doctors. MIG “Medical Book”, 2002, 112–137 pp.

3. Abelev G.I., Altshtein A.D., Deigman G.I., Dyban P.A. and others. Tumor growth as a problem in developmental biology. M., “Science”, 1979, 244 pp.

4. Abramov M.G. Hematological atlas. M., Medicine, 1985, 344 pp.

5. Almazov I.V., Sutulov L.S. Atlas of histology and embryology. M., Medicine, 1978, 544 pp.

6. Atlas of blood cells and bone marrow. /Edited by G.I.Kozints/. "Triad-X", M., 1998, 160 pp.

7. Afanasyev B.V., Almazov V.A. Progenitor hematopoietic cells in humans. L., “Science”, 1985, 204 pp.

8. Belokhvostov A.S., Novik A.A. The role of molecular genetic studies in the diagnosis of solid tumors. "Oncology Issues". T.45, No. 6, 1999, pp. 599–606. 9. Bzhadug O.B., Grivtsova L.Yu., Tupitsin N.N., Tyulyandin S.A. Circulating tumor cells in the blood of patients with locally advanced and disseminated breast cancer. “Bulletin of the Russian Oncology Research Center named after N.N. Blokhin”, T. 18, No. 3, 2007, pp. 19–21.

10. Bilibin D.P., Babichenko I.I., Khodorovich N.A. Pathophysiological and pathomorphological aspects of acute and chronic inflammation. M., Publishing house of the Russian Peoples' Friendship University. 2003, 35 pp.

11. Bochkov N.P. Clinical genetics. Textbook. M., GEOTAR-med, 2002.